Quibim

Quibim is an advanced  AI platform in healthcare  transforming medical imaging into precision health solutions. It offers tools like QP-Brain, QP-Prostate, QP-Liver, QP-Breast, QP-Lung, and QP-Insights, which automate and enhance radiological analysis for various medical conditions. With  AI medical imaging , these tools streamline diagnostics by providing precise, quantitative information, significantly reducing interpretation time and improving diagnostic accuracy. For instance, QP-Brain excels in brain volumetrics and white matter hyperintensity analysis, aiding in disease progression tracking. Meanwhile, QP-Prostate enhances prostate cancer detection by automating regional organ segmentation. Quibim's integration with existing systems ensures seamless workflow integration, making it a valuable asset in clinical and research settings.

Here are some practical use cases of Quibim's AI tools:

• Prostate Cancer Diagnosis: Quibim’s QP-Prostate tool automates the segmentation of prostate MRI images, offering detailed regional analysis. This enhances the precision of prostate cancer detection and helps in the early identification of abnormalities, reducing unnecessary biopsies and surgeries​.
• Brain Health Monitoring: QP-Brain® assists in the early detection of neurological diseases like Alzheimer’s and multiple sclerosis. It provides detailed volumetric analysis and white matter hyperintensity characterization, supporting better diagnosis and monitoring of disease progression​​.
• Liver Disease Analysis: QP-Liver quantifies fat and iron levels in liver MRIs, facilitating the evaluation of conditions like steatosis and iron overload. This automation improves diagnostic accuracy and helps clinicians manage liver diseases more effectively​.
• Breast MRI Analysis: QP-Breast enhances breast MRI analysis by detecting and quantifying abnormalities. Assists in the early detection of breast cancer, improving treatment outcomes. Provides standardized and detailed reports, aiding radiologists in making informed decisions.
• Detecting Lung Diseases: Automates the analysis of lung CT scans, helping detect lung diseases early. Quantifies lung volumes and lesions, aiding in the management of conditions like COPD and lung cancer. Integrates with existing systems to provide detailed, standardized reports.
• Clinical Research Support: QP-Insights® integrates imaging data with other clinical data to enhance research capabilities. It helps in identifying patients suitable for clinical trials and predicting treatment responses, accelerating drug development processes​​.

These use cases demonstrate how Quibim's AI tools streamline clinical workflows, enhance diagnostic accuracy, and support advanced medical research.

Quibim offers custom pricing tailored to the specific needs of its clients. To find out the pricing for your requirements, you need to become a partner with Quibim. They work closely with you to understand your needs and provide a pricing model that fits your usage and budget. Visit Quibim's website or contact their sales team for more detailed information on their pricing plans.

The team at Quibim is led by Ángel Alberich-Bayarri, the CEO & Co-Founder. Javier Sáez serves as the VP of Finance & Business Intelligence, while Alberto Valiente is the Chief Operating Officer. Jorge Navarro is the Chief People Officer, and Parco Chan oversees corporate strategy. Luis Bosque is the Chief Technology Officer (CTO), and Fuensanta Bellvís is the VP of Clinical Studies. Ana Jiménez heads AI as the VP of AI, with Josep Hortigüela managing quality and regulatory aspects as the VP of Quality and Regulatory. Claire Palacin is the VP of Marketing & Communication, Glen Weiss is the Chief Medical Officer, Pamod Hemakumara directs corporate development, and Javier Pizcueta is responsible for business development in the EMEA region.

This team combines expertise from various fields to drive Quibim’s innovation in medical imaging and AI technology.



Ángel Alberich-Bayarri

CEO & Co-Founder

Quibim has secured a total funding amount of €17 million. This funding supports the development and enhancement of their AI-powered medical imaging tools. The investment helps Quibim advance their technology, expand their product offerings, and improve diagnostic accuracy and efficiency in healthcare.